Owner Abbott Laboratories

Inventors Schmidt, Robert G. Jr.; Latshaw, Steve; Brown, S. Brian; Gomtsyan, Arthur R.; Daanen, F. Jerome; Koenig, R. John; Jinkerson, K. Tammie; Bayburt, Erol K.; Lee, Chih-Hung

Agent Spruson & Ferguson

Pub. Number AU-B-2005316972

PCT Pub. Number WO2006/065484

Priority 60/630,636 24.11.04 US

Filing date 22 November 2005

Wipo publication date 22 June 2006

Acceptance publication date 10 November 2011

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms